JAMRX
Price
$87.55
Change
-$1.33 (-1.50%)
Updated
Jun 13 closing price
Net Assets
24.49B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

JAMRX vs RGEBX

Header iconJAMRX vs RGEBX Comparison
Open Charts JAMRX vs RGEBXBanner chart's image
Janus Henderson Research T
Price$87.55
Change-$1.33 (-1.50%)
VolumeN/A
Net Assets24.49B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
JAMRX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JAMRX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAMRX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. JAMRX (24.5B). JAMRX (0.00) and RGEBX (0.00) have matching dividends . JAMRX was incepted earlier than RGEBX: JAMRX (32 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than JAMRX (0.79). JAMRX is a more actively managed with annual turnover of: 27.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than JAMRX: RGEBX (250) vs JAMRX (2500). JAMRX annual gain was more profitable for investors over the last year : 8.70 vs. RGEBX (7.68). JAMRX return over 5 years is better than : 69.65 vs. RGEBX (45.42).
JAMRXRGEBXJAMRX / RGEBX
Total Expense Ratio0.791.0972%
Annual Report Gross Expense Ratio0.791.0972%
Fund Existence32 years11 years-
Gain YTD3.4264.82971%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets24.5B306B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year8.707.68113%
Returns for 3 years88.7651.01174%
Returns for 5 years69.6545.42153%
Returns for 10 years93.4465.87142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd